Saleh Alkarim

6PUBLICATIONS
24CO-AUTHORS
Atmospheric aerosolsTumour immunologyHaematological tumoursNeurology and neuromuscular diseasesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 28, 2026
Correction: Ramadan, W.S.; Alkarim, S. Ellagic Acid Modulates the Amyloid Precursor Protein Gene via Superoxide Dismutase Regulation in the Entorhinal Cortex in an Experimental Alzheimer's Model. Cells 2021, 10, 3511.

Wafaa S Ramadan, Saleh Alkarim

|Oct 26, 2024
T-Cell Immunoglobulin and Mucin Domain 3 (TIM-3) Gene Expression as a Negative Biomarker of B-Cell Acute Lymphoblastic Leukemia.

Fatemah S Basingab, Manar Bashanfer, Aisha A Alrofaidi

|May 24, 2024
Herpesvirus Entry Mediator as an Immune Checkpoint Target and a Potential Prognostic Biomarker in Myeloid and Lymphoid Leukemia.

Fatemah S Basingab, Reem A Alzahrani, Aisha A Alrofaidi

|Oct 14, 2023
Modulation of the Tumor Microenvironment by Ellagic Acid in Rat Model for Hepatocellular Carcinoma: A Potential Target against Hepatic Cancer Stem Cells.

Wafaa S Ramadan, Saleh Alkarim, Mohammed Moulay

|Nov 11, 2022
Stem-Cell-Based Therapy: The Celestial Weapon against Neurological Disorders.

Mohamed A Zayed, Samar Sultan, Hashem O Alsaab

|Oct 26, 2022
Pharmacophore-Model-Based Virtual-Screening Approaches Identified Novel Natural Molecular Candidates for Treating Human Neuroblastoma.

F A Dain Md Opo, Saleh Alkarim, Ghadeer I Alrefaei

Pageof 1

Frequent Collaborators

3 joint publications

Ghadeer I Alrefaei

2 joint publications

Fatemah S Basingab

2 joint publications

Aisha A Alrofaidi

2 joint publications

Ahmed S Barefah